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ABSTRACT: Studying interactions between nano-carbons and lipid membranes is important for 
multiplexed drug delivery, device fabrication and for understanding toxicity. Herein, we report that 
nanodiamond (ND, sp3 carbon) forms a complex with highly biocompatible zwitterionic liposomes 
based on hydrogen bonding, which is confirmed by pH-dependent and urea-dependent assays. Despite 
such weak interaction, the complex is highly stable. Comparisons were made with two sp2 carbons: 
nanoscale graphene oxide (NGO) and carbon nanotube (CNT), where CNT adsorption is the weakest. 
Adsorption of the nano-carbons does not induce liposome leakage or affect lipid phase transition 
temperature. Therefore, the potential toxicity of nano-carbons is unlikely to be related to direct 
membrane damage. ND facilitates cellular uptake of liposomes and co-delivery of negatively charged 
calcein and positively charged doxorubicin has been demonstrated. ND has the lowest toxicity, while 
CNT and NGO are slightly more toxic. The effect of introducing fusogenic lipids and cholesterol was 
further studied to understand the effect of lipid formulation.  
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1. INTRODUCTION 
In the past few decades, carbon-based nanomaterials have tremendously fueled the growth of 
nanotechnology with the discovery of various forms of this element. From the chemical and geometric 
standpoint, the recent interests are focused on the following three materials: carbon nanotubes (CNTs, 
1-D, sp2 carbon), graphene (2-D, sp2 carbon), and nano-diamond (ND, 0-D, sp3 carbon). These nano-
carbons have been explored for biomedical applications, including imaging, drug delivery, and 
therapeutics. CNTs were historically the first explored, encouraged by its light absorption for 
hyperthermia treatment, near IR fluorescence, and drug carrying ability.1-4 Pristine graphene is very 
hydrophobic and cannot be dispersed as monolayered sheets in water. For biomedical applications, 
nanoscale graphene oxide (NGO) with oxygenated groups is often used.5-13 Recently, ND has been 
shown to be a highly biocompatible drug carrier.14-23 Being a sp3 carbon based material, the surface 
property of ND is quite different from its sp2 counterparts. While remarkable progresses have been 
made on the application side, fundamental interactions at the bio/nano interface are still not fully 
understood.24-26 
One of the most important and fundamental aspects is their interaction with lipid membranes. 
Endocytosis, pore formation and oxidative stress are all related to membrane processes. Understanding 
membrane/nanoparticle interaction may also have direct applications in sensing,27 drug delivery,28 
imaging,29 and device fabrication. Liposomes are an ideal model for the cell membrane. To attach 
nano-carbons to liposomes, the majority of the previous work employed electrostatic interactions or 
covalent linkages. For example, cationic liposomes were used to adsorb negatively charged GO.30 
Liposomes of various charges were adsorbed by graphene deposited on a wafer for device fabrication.31 
Molecular dynamics simulation showed the insertion of a graphene sheet between the hydrophobic tails 
of a bilayer,32 and the level of graphene oxidation appears to be important.33 There are also reports on 
interfacing liposomes with CNTs, where covalent attachment is often used.34-36 Recently, attempts were 
 3 
made to encapsulate ND inside liposomes.37, 38 However, little is known about the interaction between 
ND and liposomes. A systematic comparison between the different nano-carbons is also lacking. 
We are particularly interested in exploring non-covalent and non-electrostatic interactions, since 
covalent conjugation is often expensive and difficult to carry out while cationic components are always 
toxic. Being one of the major components in the cell membrane and highly biocompatible, zwitterionic 
phosphatidylcholine (PC) liposomes are particularly attractive as a model system (see Figure S1 for the 
lipid structures). We herein report that ND can be attached to PC liposomes by a simple mixing step via 
hydrogen bonding. Comparisons were made to CNT and NGO to allow mechanistic insights (Figure 
1A). Using this ND/liposome complex for co-delivery of an imaging dye and an anti-cancer drug has 
been demonstrated. 
 
2. RESULTS AND DISCUSSION 
2.1. Non-electrostatic adsorption of NDs. Our ND samples were washed extensively with 
concentrated acids to generate surface carboxyl groups, leading to a negatively charged surface (zeta-
potential = -30.5 mV at pH 6.0). IR spectroscopy indicates the presence of surface carboxyl, hydroxyl, 
and other oxygenated species (Figure S2).39 The resulting product can be readily dispersed in water 
with good colloidal stability. The size of the ND particles has a relatively large distribution as indicated 
by TEM (Figure S3). The UV-vis spectrum of our 30 nm ND sample is shown in Figure 1B (red trace), 
where only the light scattering feature is observed and shorter wavelengths scatter more strongly. For 
comparison, the UV-vis spectra of NGO and CNT are also presented; both have a well-defined 
absorption peak in the UV region. The lack of UV absorbance of our ND sample confirms the different 
chemistry between sp2 and sp3 carbons in our samples. 
To interface ND with liposomes, most previous work aimed to encapsulate ND inside 
liposomes via co-extrusion or sonication,37, 38 where improved biocompatibility and colloidal stability 
of ND might be achieved. In this work, we employed a different design by decorating ND on the 
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surface of liposomes. We reason that such a design leaves the internal compartment of liposomes free 
for drug loading while the ND surface could still adsorb drugs for multiplexed delivery, which might 
be a more efficient way to utilize the surface area of nanomaterials. The simplest way to attach ND is 
through adsorption. To test feasibility, we respectively mixed ND with cationic 1,2-dioleoyl-3-
trimethyl ammonium-propane (DOTAP), zwitterionic 1,2-dioleoyl-sn-glycero-3-phosphocholine 
(DOPC), and anionic 1,2-dioleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt) (DOPG) 
liposomes, all labeled with 1% rhodamine (Rh). After centrifugation, the supernatant contains only the 
free liposomes while liposomes decorated with ND are precipitated (Figure 2A). Both DOTAP and 
DOPC liposomes can adsorb ND since their supernatants are dark. The lack of adsorption by DOPG 
liposomes is explained by electrostatic repulsion. For drug delivery, DOPC is preferred over DOTAP 
since cationic DOTAP is highly toxic. The kinetics of ND adsorption by DOPC liposomes is quite fast 
and is finished in ~1 min after mixing (Figure S4). 
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Figure 1. (A) Schematics of adsorption of the nano-carbons onto zwitterionic PC liposomes. (B) UV-
vis spectra of the nano-carbons. Cryo-TEM micrographs of ND/DOPC (C) and CNT/DOPC (D) 
hybrids. Scale bars = 100 nm. 
 
Next we compared the adsorption of the three nano-carbons by DOPC liposomes (Figure 2B). 
Based on the lack of supernatant fluorescence, all of them can adsorb DOPC liposomes. To further 
characterize these complexes, cryo-TEM was used. The ND particles follow the contour of the 
liposome surface (Figure 1C), confirming specific adsorption interaction. CNTs (single-walled) also 
show adsorption by DOPC liposomes and no free CNTs are observed (Figure 1D). The spherical shape 
of liposomes is maintained in both systems. More cryo-TEM micrographs are presented in Figure S5. 
 6 
For many applications, especially for drug delivery, particle size and colloidal stability are very 
important. The cryo-TEM micrographs show aggregated liposome/nano-carbons, which might be 
related to sample preparation and drying. To monitor nanoparticle size in solution, dynamic light 
scattering (DLS) was carried out (Figure 2C). The hydrodynamic size of ND is ~40 nm, while NGO 
and CNT are slightly above 100 nm. The size of DOPC liposomes is ~100 nm, consistent with the 
cryo-TEM measurement. Next we respectively added increasing concentrations of each nano-carbon to 
the DOPC liposomes and the size of the complex never exceeded 200 nm for all the samples (Figure 
2D), suggesting the lack of extensive aggregation in solution. It is intriguing to observe that the average 
size of the DOPC/ND mixture actually decreased by adding more ND, which might be due to ND 
having a much stronger light scattering ability and high refractive index, dominating the light scattering 
signal. This hypothesis is confirmed by mixing DOPG liposomes and ND, where no interaction is 
expected and the size still decreases. On the other hand, when cationic DOTAP liposomes and ND are 
mixed, significant growth in size indicating aggregation is observed. This serves as a positive control to 
confirm the lack of extensive aggregation when DOPC liposomes are mixed with the nano-carbons. 
The ability to form a stable DOPC/ND conjugate is useful for cellular uptake of this complex (vide 
infra). 
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Figure 2. Photographs of ND mixed with the three types of Rh-labeled liposomes (A) and Rh-DOPC 
liposomes mixed with the three nano-carbons after centrifugation (B). Red fluorescence in the 
supernatant indicates non-adsorbed free liposomes. (C) DLS spectra of the nano-carbons and DOPC 
liposomes. (D) Change of the hydrodynamic size of DOPC liposomes as a function of nano-carbon 
concentration. (E) Adsorbed DOPC liposomes by ND as a function of pH. Inset: sample fluorescence at 
pH 5 and 9. (F) Adsorption of DOPC liposomes by nano-carbons as a function of urea concentration. 
 
2.2. Hydrogen bonding mediated adsorption. After confirming the adsorption between ND and 
DOPC liposomes, we aim to identify the origin of the attractive force. Electrostatic attraction or 
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hydrophobic interaction is unlikely to work with zwitterionic DOPC liposomes. We propose that 
hydrogen bonding might be the main force for adsorption. To test it, we measured ND adsorption as a 
function of pH, where stronger fluorescence from Rh-labeled DOPC liposomes or poor ND adsorption 
was observed at pH above 9 (Figure 2E). Effective adsorption was achieved at pH 7 or lower. The only 
possible pH-sensitive group at around neutral pH is the carboxyl or other oxygenated groups on ND. 
To further confirm hydrogen bonding, DOPC liposomes were incubated with the nano-carbons in the 
presence of 0-6 M urea (Figure 2F). Interestingly, CNT desorbed with just 2 M urea, while NGO 
showed slight desorption only with 6 M urea. ND is stable in 2 M urea but desorbs with 4 M urea. The 
disruptive effect of urea further confirms the hydrogen bonding mechanism. It is likely that the 
protonated carboxyl is the hydrogen bond donor and the phosphate on the DOPC head group is the 
acceptor. The adsorption strength of DOPC liposomes follows the order of NGO > ND > CNT. Since 
hydrogen bond is a weak force, to realize effective adsorption, a large contact area with the liposome is 
required to achieve multivalent binding. The weaker adsorption of CNT might be related to its 
geometry and the surface carboxyl groups are unlikely to concentrate on the narrow nanotube surface 
to interact with the liposomes. 
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Figure 3. (A) Calcein-loaded DOPC liposome leakage test. At time zero, DOPC liposomes were mixed 
with various nano-carbons and at 15 min, Triton X-100 was added. (B) DPPC Tc change as a function 
of nano-carbon concentration. Inset: a calcein release curve as a function of temperature. (C) Laurdan 
fluorescence as a function of ND concentration. (D) Laurdan fluorescence intensity as a function of 
nano-carbon concentration. 
 
2.3. Membrane interactions. After understanding the adsorption force, we next studied the 
biophysical effect of nano-carbon on the membrane, which is important for understanding toxicity. The 
cryo-TEM micrograph (Figure 1C) indicates that many ND particles are closely associated with the 
lipid membrane and important questions are whether ND induces liposome leakage and affects lipid 
phase transition temperature (Tc). To answer these questions, we encapsulated 100 mM calcein inside 
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DOPC liposomes to achieve the self-quenching effect. After removing free calcein, liposome leakage 
was monitored by fluorescence enhancement. Within 15 min, little leakage was observed for all the test 
nano-carbons (Figure 3A) and full rupture was induced at 15 min by adding Triton X-100. To 
understand the effect on Tc, we mixed calcein loaded 1,2-dipalmitoyl-sn-glycero-3-phospho choline 
(DPPC) liposomes with various concentrations of the nano-carbons. The samples were gradually 
heated and the fluorescence intensity was measured at each temperature. A typical response curve in 
the absence of nano-carbon is shown in the inset of Figure 3B, where the fastest leakage occurs at 40 
C, consistent with the Tc of DPPC being 41 C. With increasing carbon concentration, the Tc remains 
constant under all the tested conditions. Therefore, these materials are likely to be adsorbed only on the 
liposome surface without affecting the packing of the bilayer. To further confirm this, 6-dodecanoyl-2-
dimethylaminonaphthalene (Laurdan) dye was embedded in the bilayer region of DOPC liposomes and 
its fluorescence spectra were monitored as a function of nano-carbon concentration. The Laurdan 
fluorescence peak was at 481 nm, consistent with the dye sitting in a fluid bilayer.40-42 We only 
observed fluorescence quenching by adding nano-carbon (Figure 3C for ND; Figure S7 for NGO and 
CNT) without peak shifting. This also supports surface adsorption without disrupting the lipid packing. 
For comparison, when the dye was embedded in DPPC liposomes, the peak was at 445 nm at 25 C 
(gel phase) and 481 nm at 41 C (fluid phase) (Figure S6). Among the three nano-carbons, NGO has 
the strongest quenching ability, followed by CNT, while ND is a poor quencher (Figure 3D). 
 
2.4. Multiplexed delivery. Decorating ND on DOPC liposomes offers a useful means for multiplexed 
delivery since both the liposomes and ND are available for drug containment. Next, we tested the 
cellular uptake of this hybrid. The free Rh-DOPC liposomes cannot be internalized by HeLa cells and 
no red fluorescence was observed (Figure 4A), while NDs of 30-100 nm could carry DOPC liposomes 
into the cells (Figure C, D and Figure S8). For comparison, CNT is a poor carrier for DOPC liposomes 
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since only very weak red fluorescence was observed under the same imaging condition (Figure 4B). In 
previous reports, CNTs were linked to liposomes via biotin/avidin interaction or amide bonding to 
achieve co-delivery.34, 35 In our case, only physisorption was employed. In particular, CNT has been 
shown to be only weakly adsorbed compared to ND based on the urea assay. The zero-dimension of 
ND might also contribute to its favorable cellular uptake compared to the 1-D CNT. Using low 
temperature incubation and lysosome staining dyes, we further confirmed that cellular uptake of 
DOPC/ND is through the energy-dependent endocytosis pathway (Figure S9, S10). 
 
Figure 4. (A) Confocal fluorescence micrographs of HeLa cells incubated with free Rh-DOPC 
liposomes (A), Rh-DOPC/CNT (B), Rh-DOPC/30 nm ND (C) and Rh-DOPC/100 nm ND (D) for 4 hr. 
The cytoskeleton actin was stained in green and the nucleus was stained in blue. Inset: the red channel 
showing liposome fluorescence. 
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After establishing the feasibility of using DOPC/ND as a delivery vehicle, we next tested its 
performance. Doxorubicin (DOX) is a commonly used anti-cancer drug and we compared its 
adsorption capacity on the nano-carbons. NGO has the highest capacity followed by CNT (Figure S11). 
This is understandable since all the carbon atoms are on the surface for NGO and CNT, while NGO can 
adsorb DOX on both sides. Each mg of ND can adsorb ~0.2 mg of DOX and the presence of DOPC 
does not change the capacity. To test multiplexed delivery, we employed calcein-loaded DOPC 
liposomes. After adding ND and incubating the complex with DOX, the vehicle was incubated with the 
HeLa cells (Figure 5A). Strong calcein (green) and DOX (red) fluorescence were observed, indicating 
co-delivery of both. For comparison, calcein-loaded free DOPC liposomes were not internalized by the 
cells (Figure 5B).  
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Figure 5. (A) Confocal fluorescence micrographs of co-delivery of calcein and DOX using DOPC/ND. 
(B) Delivery of calcein loaded DOPC liposomes alone. Cell viability measured using MTT assay for 
various nano-carbons (C) and the DOPC/ND complex with DOX or free DOX (D). 
 
Next, we compared the toxicity of the nano-carbons. Consistent with the literature, ND has very 
low toxicity (Figure 5C); no growth inhibition was observed at below 20 g/mL ND.43-45 Higher 
toxicity was observed with the two sp2 carbons. When DOX was loaded, similar cancer cell killing 
efficacy was observed for the DOPC/ND vehicle compared to the free DOX. This suggests that most of 
the DOX added to the vehicle was delivered into the cells and released inside the cells. Since DOX can 
efficiently diffuse through the cell membrane, it is commonly to observe that a delivery vehicle does 
not enhance its efficacy.46, 47 Using a drug carrier on the other hand allows potential targeted delivery to 
cancer cells while free DOX can also kill healthy cells. This study presents an interesting example of 
the interaction of different nano-carbons with liposomes and the cellular uptake of the complexes. Both 
the surface chemistry of carbon and geometry appear to be important. 
2.5. Effect of lipid composition. Most of the above work was based on DOPC liposomes complexed 
with ND or other nano-carbons. Since the property of a liposome can be further tuned by introducing 
other lipid compositions, to achieve a complete understanding, we also studied the effect of adding 
charged lipids, fusogenic lipids (e.g. 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE)) and 
cholesterol. The main component was still DOPC to ensure adsorption and good biocompatibility. For 
all these studies, the imaging parameters were adjusted to be the same so that the amount of liposome 
uptake can be directly compared. First, as shown in the upper row of Figure 6, very little free liposomes 
were internalized, except for the sample with 10% DOTAP (Figure 6C). This is consistent with the 
notion that DOTAP is cationic and attracted by the negatively charged cell membrane. Increase of 
liposome uptake by adding ND was observed for all the samples, and the sample containing 30% 
DOPE showed the highest level of uptake (Figure 6E). Therefore, using ND to assist liposome uptake 
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is a general property of this system. DOPE is also a zwitterionic lipid, where its relatively small head 
group renders its fusogenic property. Introducing cholesterol appears to be detrimental for the liposome 
uptake (Figure 6D, F), while just 10% negatively charged DOPG inhibits the uptake (Figure 6B). We 
confirmed this to be related to the reduced ND adsorption by the negatively charged liposomes (Figure 
6G, Figure S12). Therefore, optimization of the cellular uptake property can be further achieved by 
varying the lipid composition.  
 
 
 
 
Figure 6. (A-F) Confocal fluorescence microscopy of HeLa cells incubated with free Rh-labeled 
liposomes (upper row) or with ND/liposome complex (bottom row) with various lipid compositions. 
Each sample is split into a red channel (Rh-lipid), a blue channel (cell nuclei) and a merged channel 
also with green fluorescence for the cell actin. (G) Photographs of free Rh-labeled liposomes (the tubes 
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on the left) and the supernatant when the same liposome was mixed with ND (the tubes on the right). 
Chol = cholesterol. 
 
 
3. MATERIALS AND METHODS 
Chemicals. All the phospholipids were purchased from Avanti Polar Lipids (Alabaster, AL). 
Monocrystalline nanodiamond powders (MSY 0-0.03, 0-0.05, 0-0.1) were purchased from 
Microdiamant AG (Lengwil, Switzerland). Carboxyl-modified single-walled carbon nanotubes (CNT) 
were purchased from SkySpring Nanomaterials Inc. (Houston, TX). GO was purchased from ACS 
Material, LLC (Medford, MA). Disodium calcein, doxorubicin hydrochloride, Triton X-100 and 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) were obtained from Sigma-Aldrich (St 
Louis, MO). Dimethyl sulfoxide (DMSO), chloroform, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic 
acid (HEPES) and NaCl were purchased from Mandel Scientific (Guelph, ON, Canada). LysoTracker 
Green, 4',6-diamidino-2-phenylindole (DAPI), 6-dodecanoyl-2-dimethylaminonaphthalene (Laurdan), 
and Alexa Fluor 488 phalloidin were from Life Technologies. All the cell culture related chemicals 
including medium, sera, and antibiotics were purchased from Fisher Scientific Inc. Mill-Q water was 
used to prepare all the buffers and solution. All other reagents and solvents were of analytical grade and 
used as received. 
Preparation of ND. Monocrystalline ND powder with sizes of 30, 50 and 100 nm were carboxylated 
following the standard procedures.39 In brief, the ND powder sample (0.5 g) was heated in a 9:1 (v/v) 
mixture of concentrated H2SO4 and HNO3 (10 mL) at 75 C for 3 days. After centrifugation to remove 
the acid and washing in water, the samples were soaked in NaOH (0.1 M) at 90 C for 2 h, and then in 
HCl (0.1 M) at 90 C for 2 h. The resulting carboxyl NDs were extensively rinsed with deionized water 
and Milli-Q water and harvested using ultracentrifugation at 50,000 rpm and dried. 
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Preparation of NGO. The large GO sheets were dispersed in water at a concentration of 0.5 mg mL-1 
and sonicated on an ultrasonic processor at a power of 120 watt 20 kHz with pulse on for 2 s and pulse 
off for 4 s for 10 h.12 After the treatment, the size of the GO sheets was decreased from micrometer to 
below 100 nm. 
Liposome preparation. Liposomes were prepared using the standard extrusion method.48 The mini-
extruder was purchased from Avanti Polar Lipids. DOPC, DOPG or DOPC/DOTAP (1:1, w/w) with a 
total mass of 2.5 mg were respectively dissolved in chloroform. Rh-labeled liposomes were prepared 
by mixing 1% Rh-PE with various lipids in chloroform. Chloroform was then removed under a gentle 
N2 flow in the fume hood and trace amounts of residual chloroform was removed by storing the 
samples in a vacuum oven overnight at room temperature. The dried lipids were kept under a N2 
environment and then stored at -20 C prior to use. To prepare liposomes, the lipids were hydrated with 
0.5 mL buffer A (100 mM NaCl, 20 mM HEPES, pH 7.6) at room temperature with occasional 
sonication for at least 2 h. Therefore, the lipid concentration was 5 mg mL-1. The resulting cloudy 
suspension was extruded through two stacked polycarbonate membrane (pore size = 100 nm) for 21 
times. After extrusion, the lipid solution appeared to be transparent, indicating downsize of the lipid 
structures and formation of liposomes.  
Calcein-loaded liposome preparation. To encapsulate calcein, the above prepared DOPC lipid film 
was hydrated with 100 mM disodium calcein solution overnight with occasional sonication to help 
dispersing the lipid.49 The sample was then extruded using 100 nm pore sized membrane and free 
calcein was removed by passing the samples through a Pd-10 column using buffer A for elution, where 
the first 600 L of the fluorescent fraction was collected. The calcein concentration in the fraction is 
estimated to be ~45 M based on the fluorescence intensity after rupturing the liposomes with Triton 
X-100. To prepare calcein loaded DPPC liposomes, the hydration step using the 100 mM calcein 
solution was carried out at 55 C for 2 hr with occasional sonication to assist mixing. All the 
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subsequent extrusion operations were carried out at this temperature. After extrusion, the free calcein 
was removed using the Pd-10 column and this step was carried out at room temperature as described 
above. 
Laurdan-loaded liposome preparation. Laurdan loaded DOPC liposomes were prepared by mixing 
10 L Laurdan (1 mM) with 500 L DOPC lipid (5 mg mL-1) in chloroform (Laurdan : DOPC lipid 
molecule = 1 : 318). Then similar procedures were carried out for extrusion as mentioned above. Note 
that the Laurdan dye was loaded in the hydrophobic bilayer region. Laurdan loaded DPPC liposomes 
were prepared in a similar way but all the operations including hydration and extrusion were carried out 
at 55 C. 
Adsorption of liposome by nano-carbons. To understand the adsorption of the various charged 
liposomes to ND, the concentration of ND was fixed at 1 mg mL-1 in buffer (10 mM HEPES, pH 7.6). 
To 100 L of the ND solution, 1 L Rh-labeled zwitterionic DOPC liposomes, anionic DOPG 
liposomes and cationic DOTAP liposomes (5 mg mL-1) were added, respectively. To study the 
adsorption of various nano-carbons by DOPC liposomes, 1 L Rh-DOPC liposomes (5 mg mL-1) were 
added to 100 L ND (1 mg mL-1), CNT (50 g mL-1) and NGO (50 g mL-1) in buffer (10 mM MES, 
pH 6.0), respectively. After centrifugation at 70,000 rpm to precipitate the nano-carbons, the 
fluorescence of the samples was observed under UV light in a dark room. The supernatant fluorescence 
was photographed using a digital camera. The same procedures were used to observe liposome 
adsorption by ND in different pH. pH was adjusted with a final of 10 mM citrate buffer (pH 3, 4, 5, 6) 
or HEPES buffer (pH 7.6). NaOH was used to adjust pH to 9 and 11. To further confirm hydrogen 
bonding, DOPC liposomes were incubated with the three nano-carbons at pH 6 with 0, 2, 4, and 6 M 
urea. The fluorescence was observed under a handheld UV lamp excitation in a dark room. For 
documentation, a digital camera was used (Canon PowerShot SD 1200 IS). 
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4. CONCLUSIONS 
In summary, we reported a simple method to attach ND to zwitterionic liposomes based on hydrogen 
bonding. The ND/liposome complex is highly stable and is disrupted only with 4 M urea or at high pH. 
For comparison, CNTs are adsorbed much weaker. Both DOPC liposomes and ND are highly 
biocompatible, making this design attractive for drug delivery. Another advantage is that both the 
interior of liposome and the ND surface can be used for drug loading. We demonstrated this by co-
delivery of calcein and doxorubicin. The adsorption of nano-carbons to the liposomes has very little 
effect on the membrane integrity or Tc, suggesting that the nano-carbons are only adsorbed by the 
membrane surface without disrupting the packing of the hydrophobic lipid tails. Therefore, the toxicity 
of these nano-carbons might not be related to their direct interaction with the cell membrane. Further 
optimization for cellular uptake has been achieved by introducing fusogenic DOPE lipid. Overall, this 
work has opened a door to rational engineering of the lipid/nano-carbon interface based on weak 
intermolecular forces.  
SUPPORTING INFORMATION 
Additional methods, IR, adsorption kinetics, TEM, confocal micrographs, DOX adsorption capacity. 
This material is available free of charge via the Internet at http://pubs.acs.org.  
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